Table 3. Table 3. Immunological parameters and systemic inflammation markers among patients with episodic schizophrenia (n=20), continuous schizophrenia (n=16) and among the controls (n=30).

The results are presented as Median (25 quartile; 75 quartile). * - differences with controls, p<0.05. ** - differences between groups, p<0.05.

Parameters		Episodic schizophrenia	Continuous schizophrenia	Controls
Humoral component parameters	IgA, [g/l]	2.97 (2.31; 3.35)	3.09 (2.17; 3.23)	2.79 (2.58; 3.09)
	IgM, [g/l]	1.43 (0.93; 2.09)	1.05 (0.73; 1.46)	0.9435 (0.71; 1.3)
	IgG, [g/l]	13.69 (9.73; 15.19)	13.62 (11.07; 15.81)	12.74 (10.15; 14.44)
	CIC, [units]	73 (58; 104)**	103 (84; 192)*,**	76 (54; 95.5)
Acute phase proteins, signalling proteins (cytokines)	CRP, [mg/l]	5.48 (0.81; 20.33)*	3.3 (1.93; 8.4)*	1.08 (0.38; 2.53)
	IL-4, [pg/ml]	2.33 (1.72; 4.61)	3.5 (1.06; 5.13)	4.19 (1.39; 8.31)
	IL-10, [pg/ml]	5.03 (2.62; 6.76)	5.91(3.03; 8.28)	4.28 (1.39; 8.31)
	IFNγ, [pg/ml]	44.69 (26.88; 138.78)	44.69 (19.38; 83.33)	28.5335 (20.31; 44.32)
	IL-8, [pg/ml]	34.54 (11.19; 214.76)*	40.16 (12.61; 94.15)*	11.81 (7.31; 23.59)
	TNFα, [pg/ml]	2.09 (1.75; 3.08)	1.62 (1.30; 2.23)	1.69 (1.40; 2.84)
	IL-6, [pg/ml]	6.27 (4.02; 67.20)	5.39 (2.55; 10.85)	4.262 (2.42; 8.27)
Cell-mediated component parameters	CD45+CD3+, [%]	77.60 (74.60; 79.50)**	71.05 (68.40; 74.20)**	75.95 (71.85;78.20)
	CD45+CD3+CD4+, [%]	44.00 (39.20; 47.70)	39.95 (38.10; 44.00)	43.65 (36.60; 48.40)
	CD45+CD3+CD8+, [%]	25.8 21.40; 31.20)	23.85 (22.00; 28.80)	26.3 (23.8; 27.00)
	CD45+CD3+CD4+CD25+CD127-, [%]	3.3(2.65; 3.45)	1.85 (1.40; 3.05)	2.45 (2.15; 3.30)
	CD45+CD3+CD4+CD25+CD127- % from CD45+CD3+CD4+ lymphocytes, [%]	6.85 (6.05; 7.50)*	4.90 (3.6; 6.9)	4.75 (4.60; 5.55)
	CD45+CD3-CD16/56+, [%]	10.60 (7.10; 13.40)	11.90 (9.60; 16.50)	11.90 (8.30; 16.50)
	CD45+CD3+CD16/56+, [%]	3.40 (2.40; 6.40)	3.90 (2.60; 8.00)	4.9 (1.30; 7.50)
	CD45+CD3-CD19+, [%]	10.40 (8.00; 13.00)**	14.00 (11.00; 18.30)*,**	11.40 (9.70; 12.20)